NASDAQ
GeneLink, Inc. (GNLKQ) has a free cash flow growth of 57.21% as of Friday, May 29, 2026. This represents a 236.70% increase compared to its 12-month average of 16.99%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.